Jennifer Davis Email & Phone Number

Seattle Wa

Assay DevelopmentProtein Purification and down stream processingVaccine Development

1616 Eastlake Ave East, Seattle Wa 98102

Cell culture, protein expression

Woodinville Washington

BioPlex Division

Path

Diabetes Program focusing on screening methods for Gestational Diabetes. Assay development

Seattle Genetics

Provided support to the Experimental Therapeutics, Antibody Engineering Group for on going projects. Performing tissue culture, transfections, cell based assays utilizing flow cytometery, protein purification and quantitation. Molecular biology techniques SDS Page, Western blot analysis, plasmid production and purification (small and large scale) and associated analysis techniques. Antibody production and purification; Custom labeling of reagents; Plasmid DNA purification; Cell culture; Luminex and ELISA based methods; Updated protocols and generating process related worksheets.

Immune Design Corp, Seattle, Wa

Responsible for the development, transfer and qualification of ligand binding assays and related assays for use in development and monitoring of target related protein culture, purification and dose formulation and stability studies of vaccine candidates. Responsible for study related analysis and reporting. • Developed assays for support of novel proteins and technologies.• Managed the adjuvant inventory for internal and external collaboration.• Contributed to the development of QC department and GxP infrastructure.• Initiated and developed standard operating procedures for both regulated and research activities.• Provided documentation and reporting of in-process and qualification/characterization data for internal and external projects.• Supervised a laboratory associate responsible for basic lab functions.

Worksource Lynnwood Wa

Participant of a professional networking group at Worksource Lynnwood.

Snbl Usa, Ltd., Everett, Wa

Responsible for the development, transfer and validation of general and study specific ligand binding assays and related assays for use in GLP and non-GLP preclinical and clinical studies. Developed study related analysis and reporting. • Contributing scientist, principal investigator or analytical study director for bioanalytical validation and study related activities. • Provided documentation and reporting of bioanalytical study data for GLP and non-GLP studies. • Communicated study activity to both internal and external Study Directors, Study Monitors and Clients. • Performed flow cytometric techniques for monitoring cellular phenotype, test article and anti-test article interactions

Signature Biosciences, Inc. San Francisco, Ca

Responsible for the lab set up, technology transfer and training of staff in the tissue processing and cell based high through put screening technology obtained from the purchase of PrimeCyte Inc.

Signature Biosciences Formerly Primectye Inc., Seattle, Wa

Project focus was to relocate the lab from Seattle to San Francisco. Transfering the technology, supplies and equipment and training staff on the tissue processing and screening technologies aquired from CellPath Inc.

Primecyte, Inc., Formerly Cellpath Inc., Seattle, Wa

Responsible for procurement of tissues from collaborating Hospitals and isolation of cells from primary tissues using proprietary methods developed at PrimeCyte. Performed cell based High Throughput Screening (HTS) assays using Alamar clue and calcein AM methodologies. • Provided documentation, inventory and management of compound libraries. • Developed assay related to the cell based screening assays, Cytection technology.• Communicated with clients and collaborators about compound collections and screening of compound libraries. • Wrote Standard Operating Procedures, supporting screening documentation and assay descriptions for proprietary methodologies

Fred Hutchinson Cancer Research Center, Seattle, Wa

Responsible for the research lab and the day to day operations of the lab, staff and projects. Involved in clinical research investigating bone marrow transplantation, Graft versus Host disease and T cell involvement in graft rejection. • Routine flow cytometric phenotyping pre- and post transplant monitoring of clinical study patients. • Analysis and reporting research and study data internally and externally. • Maintained lab records on clinical study patients, collection and storage of patient samples. • Measurement of levels of therapeutic agents and antibodies to the therapeutic agents using ELISA and flow cytometry for research and clinical studies. • Responsible for T cell research related to graft rejection and graft versus host disease.